Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAVITA INC. Director's Dealing 2012

Nov 8, 2012

30643_dirs_2012-11-08_9c8ec3ca-1bf5-41bb-85e2-8a369adaef1c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2012-11-06

Reporting Person: Kogod Dennis (Chief Operating Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-11-06 Common Stock M 29166 $46.26 Acquired 68353 Direct
2012-11-06 Common Stock F 12088 $111.62 Disposed 56265 Direct
2012-11-06 Common Stock S 17078 $111.6789 Disposed 39187 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-11-06 Stock Appreciation Right $46.26 M 29166 Disposed 2014-03-02 Common Stock (29166) Direct

Footnotes

F1: The range of prices for the sale of these shares was $111.44 - $111.82. The filer undertakes to provide staff, the issuer or a security holder full information regarding the number of shares sold at each separate price.

F2: Stock Appreciation Right, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, 8.33% on the 20th month following the grant date, and 8.33% every four months thereafter.